Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol |
| |
| Authors: | Suzanne Nielsen Michala Kowalski Pene Wood Sarah Larney Raimondo Bruno Marian Shanahan Simon Lenton Paul Dietze Traci Green Bridin Murnion Alison Ritter |
| |
| Affiliation: | 1. National Drug and Alcohol Centre, University of New South Wales, Sydney, Australia;2. Monash Addiction Research Centre, Monash University, Melbourne, Australia;3. Latrobe University, Bendigo, Victoria, Australia;4. Western Victoria Primary Health Network, Geelong, Victoria, Australia;5. School of Medicine, University of Tasmania, Hobart, Australia;6. National Drug Research Institute, Curtin University, Perth, Australia;7. The Centre for Population Health, Burnet Institute, Melbourne, Victoria, Australia;8. The School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia;9. Department of Epidemiology, Brown University School of Public Health, Rhode Island, USA;10. Boston Medical Center, Injury Prevention Center, Boston University School of Medicine, Boston, USA;11. Department of Addiction Medicine, University of Sydney, Sydney, Australia;12. Drug Policy Modelling Program, University of New South Wales, Sydney, Australia |
| |
| Abstract: | BackgroundIncreases in opioid use and related harms such as mortality are occurring in many high income countries. Community pharmacists are often in contact with patients at risk of opioid-related harm and represent an ideal point for intervention. Best practice in monitoring opioid-related outcomes involves assessing analgesia, pain functioning, mood, risks and harms associated with opioid use. Community pharmacists are well-placed to undertake these tasks.ObjectivesOur pilot study will test the implementation of a computer-facilitated screening and brief intervention (SBI). The SBI will support pharmacist identification of opioid-related problems and provide capacity for brief intervention including verbal reinforcement of tailored information sheets, supply of naloxone and referral back to the opioid prescriber. The SBI utilises software that embeds study procedures into dispensing workflow and assesses opioid outcomes with domains aligned with a widely accepted clinical framework.MethodsWe will recruit and train 75 pharmacists from 25 pharmacies to deliver the Routine Opioid Outcome Monitoring (ROOM) SBI. Pharmacists will complete the SBI with up to 500 patients in total (20 per pharmacy). Data will be collected on pharmacists’ knowledge and confidence through pre- and post-intervention online surveys. Data on feasibility, acceptability and implementation outcomes, including naloxone supply, will also be collected.Project impactOur study will examine changes in pharmacists’ knowledge and confidence to deliver the SBI. Through the implementation pilot, we will establish the feasibility and acceptability of a pharmacist SBI that aims to improve monitoring and clinical management of patients who are prescribed opioids. |
| |
| Keywords: | Corresponding author. Monash Addiction Research Centre, Monash University, Peninsula Campus, Frankston, VIC 3199, Australia. Implementation study Opioids Pharmacy practice Community pharmacy Overdose Naloxone |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
